Dr. Stephen Freedman Joins Ingenium as Executive Vice President, Corporate Development
Prior to joining the company, Dr. Freedman supported Ingenium in the capacity of an expert in drug discovery and development. Dr. Freedman's pharmaceutical industry experience includes more than 10 years at Elan Pharmaceuticals, his last position being Senior Vice President, Head of Global Research at Elan's San Francisco site. Prior to Elan, Dr. Freedman spent over 12 years at Merck & Co., Inc. He received his Ph.D. in Pharmacology from the University of Southampton, England.
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.